Onkologie (Kinder- und Jugendmedizin)
Neutropenie-Management
Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia. (öffnet neues Fenster)
Quelle: Med Pediatr Oncol 1999;32(5):331-5.
Indiziert: PubMed 10219333
DOI: 10.1002/(sici)1096-911x(199905)32:5<331::aid-mpo4>3.0.co;2-m
https://www.ncbi.nlm.nih.gov/pubmed/10219333 (öffnet neues Fenster)
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. (öffnet neues Fenster)
Quelle: J Clin Oncol 2012;30(35):4427-38.
Indiziert: PubMed 22987086
DOI: 10.1200/JCO.2012.42.7161
https://www.ncbi.nlm.nih.gov/pubmed/22987086 (öffnet neues Fenster)
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. (öffnet neues Fenster)
Quelle: J Clin Oncol 2000;18(7):1517-24.
Indiziert: PubMed 10735900
DOI: 10.1200/JCO.2000.18.7.1517
https://www.ncbi.nlm.nih.gov/pubmed/10735900 (öffnet neues Fenster)
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. (öffnet neues Fenster)
Quelle: N Engl J Med 1997;336(25):1781-7.
Indiziert: PubMed 9187068
DOI: 10.1056/NEJM199706193362503
https://www.ncbi.nlm.nih.gov/pubmed/9187068 (öffnet neues Fenster)